市場調查報告書
商品編碼
1558317
2030年紅景天萃取物的全球市場預測:原產地、形態、紅景天苷濃度、用途、通路、區域分析Rhodiola Extract Market Forecasts to 2030 - Global Analysis By Nature (Organic and Conventional), Form (Powder, Liquid and Tablet/Capsule), Salidroside Concentration, Application, Distribution Channel and Geography |
根據 Stratistics MRC 的數據,2024 年全球紅景天萃取物市場規模將達到 31 億美元,預計到 2030 年將達到 47 億美元,預測期內複合年成長率為 7.4%。
紅景天萃取物是紅景天植物的濃縮形式,該植物以其適應原特性而聞名,可以幫助身體抵抗物理、化學和環境壓力。這種萃取物含有活性化合物,如玫瑰醇和紅景天苷,它們被認為可以增強精神和身體機能,減少疲勞,改善情緒。紅景天萃取物廣泛用於藥品、化妝品和營養食品,其潛在益處被認為有助於改善整體健康。
根據世界衛生組織 (WHO) 的說法,紅景天根和根莖歷來被用來改善記憶、減輕壓力(適應性特性)、抗癌和刺激中樞神經系統。
對適應原的需求不斷成長
消費者對自然健康和壓力管理的興趣正在推動對紅景天萃取物等適應原的需求激增。隨著人們越來越認知到適應原在對抗壓力和疲勞以及改善整體健康方面的潛在益處,越來越多的消費者將這些補充品納入他們的日常生活中。與壓力相關的疾病盛行率上升以及向預防性醫療保健的轉變進一步加速了這一趨勢。紅景天萃取物用途廣泛,可用於多種用途,從營養食品到機能性食品再到食品和飲料,有助於擴大其市場佔有率。
科學依據有限
紅景天萃取物具有悠久的傳統使用歷史,但缺乏對其功效和長期安全性的廣泛臨床研究是市場成長的主要限制因素。許多與紅景天萃取物相關的健康聲明都是基於初步研究和軼事證據,可能不符合某些市場嚴格的監管標準。這種科學上的不確定性使得製造商很難獲得某些健康聲明的核准,並阻止一些消費者和醫療保健專業人員充分接受基於紅景天的產品,這可能會限制受監管領域的市場擴張。
擴大網路零售平台
電子商務和線上零售平台的快速成長對於紅景天萃取物市場來說是一個巨大的機會。這些數位管道為製造商和品牌提供了繞過傳統分銷障礙並直接接觸全球消費群的機會。這個線上平台還透過詳細的產品資訊、用戶評論和專家內容提供消費者教育機會,有助於提高對紅景天萃取物產品的信任和認知。網路購物的便利性,加上消費者在網上購買保健補充品的舒適度的提高,預計將推動銷售。
雜質和品管問題
紅景天萃取物市場面臨雜質和品管問題的重大威脅。隨著需求的成長和野生紅景天變得越來越稀有,廉價、無效或潛在有害物質進入產品的風險也在增加。不同地區和製造商的品質標準不一致可能會導致產品中的活性化合物含量不同,從而損害消費者的信心和功效。這些品質問題可能會導致監管審查和負面宣傳,損害紅景天產品的聲譽並減緩市場成長。
COVID-19 大流行最初擾亂了紅景天萃取物的供應鏈和製造流程。然而,消費者對增強免疫力和減輕壓力的補充品的興趣也增加,從而推動了需求。疫情加速了向電子商務的轉變,有利於紅景天產品的線上銷售。從長遠來看,對健康和保健的日益關注可能會維持對紅景天萃取物等適應性補充品的需求增加。
3%紅景天苷部分預計將在預測期內成為最大的部分
預計紅景天苷 3% 部分在預測期內將佔據最大的市場佔有率。由於其功效和成本效益的最佳平衡,該細分市場在紅景天萃取物市場中佔據主導地位。這種濃度在補充品製造商中很受歡迎,因為它因其治療功效而被廣泛認可,尤其是減輕壓力和增強認知。 3% 紅景天苷萃取物具有標準化功效,可滿足許多市場的監管要求,同時為消費者帶來顯著益處。廣泛用於從膠囊到機能飲料的各種配方,有助於在預測期內佔據顯著的市場佔有率並持續成長。
醫療保健和製藥業預計在預測期內複合年成長率最高
在預測期內,醫療保健和製藥業將見證紅景天萃取物市場的最高成長率。這是因為紅景天潛在醫療用途的研究越來越多。隨著越來越多的臨床研究探索紅景天對壓力相關疾病、認知功能和身體表現的影響,製藥公司對開發基於紅景天的藥物和營養食品越來越感興趣。將天然化合物納入主流醫學的日益成長的趨勢也推動了該領域的成長。此外,紅景天萃取物在個人化醫療和心理健康治療方面的潛力正在吸引醫療保健領域的投資和創新。
由於其完善的營養補充品食品和消費者對天然保健食品的高度認知,預計北美將主導紅景天萃取物市場。該地區擁有強大的補充品法律規範,對壓力管理和認知健康解決方案日益濃厚的興趣正在促進市場成長。北美在天然產品方面擁有強大的研發活動和願意花錢購買優質補充品的龐大消費者基礎,進一步鞏固了主導地位。主要補充品製造商和廣泛的分銷網路的存在也支持了該地區的主導市場佔有率。
預計亞太地區的紅景天萃取物市場成長率最高。該地區中階的快速成長、健康意識的增強以及可支配收入的增加正在推動對天然保健產品的需求。許多亞洲國家傳統上使用中草藥,並且與紅景天的特性相匹配,有助於市場接受。中國、日本和韓國等國家不斷擴大的食品和機能性食品產業正在為紅景天萃取物的應用創造新的機會。此外,該地區電子商務基礎設施的開拓正在增加產品准入和市場滲透率。
According to Stratistics MRC, the Global Rhodiola Extract Market is accounted for $3.1 billion in 2024 and is expected to reach $4.7 billion by 2030, growing at a CAGR of 7.4% during the forecast period. Rhodiola extract is a concentrated form of the Rhodiola rosea plant, known for its adaptogenic properties, which help the body resist physical, chemical, and environmental stress. The extract contains active compounds like rosavins and salidrosides, which are believed to enhance mental and physical performance, reduce fatigue, and improve mood. Pharmaceuticals, cosmetics, and dietary supplements widely use Rhodiola extract for its potential benefits in promoting overall health and well-being.
According to the World Health Organization, rhodiola roots and rhizomes are traditionally used to improve memory, reduce stress (adaptogenic action), fight cancer, and stimulate the central nervous system.
Growing demand for adaptogens
The increasing consumer interest in natural health solutions and stress management has fueled a surge in demand for adaptogens like Rhodiola extract. As awareness of the potential benefits of adaptogens in combating stress, fatigue, and improving overall well-being grows, more consumers are incorporating these supplements into their daily routines. This trend is further amplified by the rising prevalence of stress-related disorders and a shift towards preventive healthcare. The versatility of rhodiola extract in various applications, from dietary supplements to functional foods and beverages, is also contributing to its expanding market presence.
Limited scientific evidence
While rhodiola extract has a long history of traditional use, the lack of extensive, large-scale clinical studies on its efficacy and long-term safety poses a significant restraint to market growth. Many health claims associated with rhodiola extract are based on preliminary research or anecdotal evidence, which may not meet the stringent regulatory standards in some markets. This scientific uncertainty can make it challenging for manufacturers to obtain approvals for certain health claims and may deter some consumers and healthcare professionals from fully embracing Rhodiola-based products, potentially limiting market expansion in regulated sectors.
Expansion of online retail platforms
The rapid growth of e-commerce and online retail platforms presents a significant opportunity for the Rhodiola extract market. These digital channels provide manufacturers and brands with direct access to a global consumer base, bypassing traditional distribution barriers. Online platforms also offer opportunities for consumer education through detailed product information, user reviews, and expert content, helping to build trust and awareness around Rhodiola extract products. The convenience of online shopping, coupled with the increasing consumer comfort with purchasing health supplements online, is expected to drive sales.
Adulteration and quality control issues
The rhodiola extract market faces a significant threat from adulteration and quality control issues. As demand grows and wild Rhodiola becomes scarcer, there's an increased risk of product adulteration with cheaper, ineffective, or potentially harmful substances. Inconsistent quality standards across different regions and manufacturers can lead to products with varying levels of active compounds, potentially undermining consumer trust and efficacy. These quality concerns could lead to regulatory scrutiny and negative publicity, potentially damaging the reputation of Rhodiola products and slowing market growth.
The COVID-19 pandemic initially disrupted supply chains and manufacturing processes for Rhodiola extract. However, it also increased consumer interest in immune-boosting and stress-reducing supplements, driving demand. The pandemic accelerated the shift towards e-commerce, benefiting online sales of Rhodiola products. Long-term, the increased focus on health and wellness may sustain higher demand for adaptogenic supplements like rhodiola extract.
The 3% salidroside segment is expected to be the largest during the forecast period
The 3% salidroside segment is anticipated to hold the largest market share during the forecast period. This segment dominates the Rhodiola extract market due to its optimal balance of potency and cost-effectiveness. This concentration is widely recognized for its therapeutic benefits, particularly in stress reduction and cognitive enhancement, making it popular among supplement manufacturers. The 3% salidroside extract offers a standardized potency that meets regulatory requirements in many markets while providing noticeable benefits to consumers. Its widespread use in various formulations, from capsules to functional beverages, contributes to its large market share and continued growth in the forecast period.
The healthcare and pharmaceuticals segment is expected to have the highest CAGR during the forecast period
The healthcare and pharmaceuticals segment is poised for the highest growth rate in the rhodiola extract market during the forecast period. This is due to increasing research into its potential medical applications. As more clinical studies explore Rhodiola's effects on stress-related disorders, cognitive function, and physical performance, pharmaceutical companies are showing greater interest in developing Rhodiola-based drugs or nutraceuticals. The growing trend of integrating natural compounds into mainstream medicine is also driving this segment's growth. Additionally, the potential for rhodiola extract in personalized medicine and mental health treatments is attracting investment and innovation in the healthcare sector.
North America is anticipated to dominate the rhodiola extract market due to its well-established dietary supplement industry and high consumer awareness of natural health products. The region's strong regulatory framework for supplements and growing interest in stress management and cognitive health solutions contribute to market growth. North America's robust research and development activities in natural products, coupled with a large consumer base willing to spend on premium health supplements, further solidify its leading position. The presence of major supplement manufacturers and extensive distribution networks also support the region's dominant market share.
Asia Pacific is expected to experience the highest growth rate in the rhodiola extract market. The region's rapidly growing middle class, increasing health consciousness, and rising disposable incomes are fueling demand for natural health products. Traditional use of herbal medicines in many Asian countries aligns well with Rhodiola's properties, facilitating market acceptance. The expanding nutraceutical and functional food industries in countries like China, Japan, and South Korea are creating new opportunities for Rhodiola extract applications. Additionally, the region's developing e-commerce infrastructure is enhancing product accessibility and market penetration.
Key players in the market
Some of the key players in Rhodiola Extract Market include Herbo Nutra, Nutra Green, Dongguan Meiherb Biotech, Golden Horizon Biologics, Lanyor, Nutragreenlife, Hanzhong TRG Biotech, Bioway (Xi'an) Organic Ingredients, Ningbo J&S Botanics Inc., Organic Herb, Xi'an LiSun Biological Technology Co. Ltd., Shanxi NHK Technology, Fooding Group, and Beijing Refine Biology.
In June 2023, in a significant development for the plant-based protein industry, Bioway recently met and interviewed Roberto, the head of procurement for the Brazilian subsidiary of a renowned multinational company, SW. The meeting took place at the prestigious Shanghai Food Ingredients Asia & Health Ingredients (FIA&CPHI) exhibition, setting the stage for a promising partnership. During their conversation, Bioway and Roberto discussed the increasing demand for organic protein products in Brazil and South America as a whole. To cater to this growing market, Roberto confirmed that the annual order quantity for the SW subsidiary would be no less than 600 tons of Bioway's organic pea protein and organic pumpkin seed protein powder. This exciting collaboration aims to open up a bigger market for Bioway's products in Brazil.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.